52

Oxygenta Pharmaceutical LtdBOM 524636 Stock Report

Last reporting period 31 Mar, 2023

Updated 31 Oct, 2024

Last price

Market cap $B

0.005

Micro

Exchange

XBOM - Bombay Stock Exchange

View Section: Price ratios

Oxygenta Statements

52

Data from Oxygenta`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

INR - Indian rupee

Last reporting period:

31 Mar, 2023

Next reporting period:

27 Sep, 2023

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

12 Nov, 2024

Oxygenta Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

INR (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2023-03-31
%

160.38

164.8 %

100

190.97

117.5

-30.591

-285.2 %

-17.5

0

8.108

6.6

20.626

200.2 %

17

-51.217

-245.8 %

-34.5

-11.386

-11.5

-6.85

-3.4

-73.429

-214.4 %

-50

1.983

2.4

-75.412

-222.9 %

-52.4

-5.305

14.212

2022-09-30
%

60.564

100

68.505

113.1

-7.941

-13.1

0

2.871

4.7

6.87

11.3

-14.811

-24.5

-0.999

-1.6

-4.177

-6.9

-23.357

-38.6

0

-23.357

-38.6

-1.651

14.143

View Section: Balance Sheet